These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 24980502)

  • 21. Mutant VPS35-D620N induces motor dysfunction and impairs DAT-mediated dopamine recycling pathway.
    Huang Y; Huang H; Zhou L; Li J; Chen X; Thomas J; He X; Guo W; Zeng Y; Low BC; Liang F; Zeng J; Ross CA; Tan EK; Smith W; Pei Z
    Hum Mol Genet; 2022 Nov; 31(22):3886-3896. PubMed ID: 35766879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VPS35, the Retromer Complex and Parkinson's Disease.
    Williams ET; Chen X; Moore DJ
    J Parkinsons Dis; 2017; 7(2):219-233. PubMed ID: 28222538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial and Clearance Impairment in p.D620N VPS35 Patient-Derived Neurons.
    Hanss Z; Larsen SB; Antony P; Mencke P; Massart F; Jarazo J; Schwamborn JC; Barbuti PA; Mellick GD; Krüger R
    Mov Disord; 2021 Mar; 36(3):704-715. PubMed ID: 33142012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinson's disease-linked
    Chen X; Kordich JK; Williams ET; Levine N; Cole-Strauss A; Marshall L; Labrie V; Ma J; Lipton JW; Moore DJ
    Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5765-5774. PubMed ID: 30842285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered striatal dopamine levels in Parkinson's disease VPS35 D620N mutant transgenic aged mice.
    Vanan S; Zeng X; Chia SY; Varnäs K; Jiang M; Zhang K; Saw WT; Padmanabhan P; Yu WP; Zhou ZD; Halldin C; Gulyás B; Tan EK; Zeng L
    Mol Brain; 2020 Dec; 13(1):164. PubMed ID: 33261640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SWIP mediates retromer-independent membrane recruitment of the WASH complex.
    Dostál V; Humhalová T; Beránková P; Pácalt O; Libusová L
    Traffic; 2023 May; 24(5):216-230. PubMed ID: 36995008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the VPS35 D620N mutation in Parkinson's disease.
    Mohan M; Mellick GD
    Parkinsonism Relat Disord; 2017 Mar; 36():10-18. PubMed ID: 27964832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VPS35 pathogenic mutations confer no dominant toxicity but partial loss of function in Drosophila and genetically interact with parkin.
    Malik BR; Godena VK; Whitworth AJ
    Hum Mol Genet; 2015 Nov; 24(21):6106-17. PubMed ID: 26251041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endosomal dysfunction in iPSC-derived neural cells from Parkinson's disease patients with VPS35 D620N.
    Bono K; Hara-Miyauchi C; Sumi S; Oka H; Iguchi Y; Okano HJ
    Mol Brain; 2020 Oct; 13(1):137. PubMed ID: 33032646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased copper toxicity in Saccharomyces cerevisiae lacking VPS35, a component of the retromer and monogenic Parkinson disease gene in humans.
    Sowada N; Stiller B; Kubisch C
    Biochem Biophys Res Commun; 2016 Aug; 476(4):528-533. PubMed ID: 27262440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Actin polymerization in the endosomal pathway, but not on the Coxiella-containing vacuole, is essential for pathogen growth.
    Miller HE; Larson CL; Heinzen RA
    PLoS Pathog; 2018 Apr; 14(4):e1007005. PubMed ID: 29668757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting.
    Williams ET; Glauser L; Tsika E; Jiang H; Islam S; Moore DJ
    Hum Mol Genet; 2018 Sep; 27(18):3189-3205. PubMed ID: 29893854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model.
    Chiu CC; Weng YH; Huang YZ; Chen RS; Liu YC; Yeh TH; Lu CS; Lin YW; Chen YJ; Hsu CC; Chiu CH; Wang YT; Chen WS; Liu SY; Wang HL
    Cell Death Dis; 2020 Nov; 11(11):1018. PubMed ID: 33257649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of molecular heterogeneity in SNX27-retromer-mediated endosome-to-plasma-membrane recycling.
    McGough IJ; Steinberg F; Gallon M; Yatsu A; Ohbayashi N; Heesom KJ; Fukuda M; Cullen PJ
    J Cell Sci; 2014 Nov; 127(Pt 22):4940-53. PubMed ID: 25278552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VPS35 mutations in Parkinson disease.
    Vilariño-Güell C; Wider C; Ross OA; Dachsel JC; Kachergus JM; Lincoln SJ; Soto-Ortolaza AI; Cobb SA; Wilhoite GJ; Bacon JA; Behrouz B; Melrose HL; Hentati E; Puschmann A; Evans DM; Conibear E; Wasserman WW; Aasly JO; Burkhard PR; Djaldetti R; Ghika J; Hentati F; Krygowska-Wajs A; Lynch T; Melamed E; Rajput A; Rajput AH; Solida A; Wu RM; Uitti RJ; Wszolek ZK; Vingerhoets F; Farrer MJ
    Am J Hum Genet; 2011 Jul; 89(1):162-7. PubMed ID: 21763482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson Disease-linked Vps35 R524W Mutation Impairs the Endosomal Association of Retromer and Induces α-Synuclein Aggregation.
    Follett J; Bugarcic A; Yang Z; Ariotti N; Norwood SJ; Collins BM; Parton RG; Teasdale RD
    J Biol Chem; 2016 Aug; 291(35):18283-98. PubMed ID: 27385586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease.
    Chen X; Tsika E; Levine N; Moore DJ
    Mol Neurodegener; 2023 Aug; 18(1):51. PubMed ID: 37542299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired neurogenesis in the hippocampus of an adult VPS35 mutant mouse model of Parkinson's disease through interaction with APP.
    Jiang M; Tu HT; Zhang K; Zhang W; Yu WP; Xu J; Tan EK; Guo KH; Zeng L
    Neurobiol Dis; 2021 Jun; 153():105313. PubMed ID: 33636388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane recruitment of the cargo-selective retromer subcomplex is catalysed by the small GTPase Rab7 and inhibited by the Rab-GAP TBC1D5.
    Seaman MN; Harbour ME; Tattersall D; Read E; Bright N
    J Cell Sci; 2009 Jul; 122(Pt 14):2371-82. PubMed ID: 19531583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of VPS35 D620N mutation on alternative autophagy and its reversal by estrogen in Parkinson's disease.
    Shiraishi T; Bono K; Hiraki H; Manome Y; Oka H; Iguchi Y; Okano HJ
    Cell Mol Life Sci; 2024 Feb; 81(1):103. PubMed ID: 38409392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.